BIOTRONIK Announces The First U.S. Implant Of Lumax 540 Series – A Therapy For Patients Suffering From Heart Failure

LAKE OSWEGO, Ore.--(BUSINESS WIRE)--BIOTRONIK, Inc., announced today the first U.S. implant of the next-generation Lumax 540 Series defibrillator for treating patients with heart failure. The Lumax 540 Series was recently approved by the U.S. Food and Drug Administration (FDA).

MORE ON THIS TOPIC